200 related articles for article (PubMed ID: 28213391)
1. The Politics and Policies of Regulating Generics in Latin America: A Survey of Seventeen States.
Sweet CM
J Health Polit Policy Law; 2017 Jun; 42(3):485-512. PubMed ID: 28213391
[TBL] [Abstract][Full Text] [Related]
2. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
[TBL] [Abstract][Full Text] [Related]
3. What is the impact of intellectual property rules on access to medicines? A systematic review.
Tenni B; Moir HVJ; Townsend B; Kilic B; Farrell AM; Keegel T; Gleeson D
Global Health; 2022 Apr; 18(1):40. PubMed ID: 35428250
[TBL] [Abstract][Full Text] [Related]
4. A proposal for measuring the degree of public health-sensitivity of patent legislation in the context of the WTO TRIPS Agreement.
Chaves GC; Oliveira MA
Bull World Health Organ; 2007 Jan; 85(1):49-56. PubMed ID: 17242758
[TBL] [Abstract][Full Text] [Related]
5. [Evolution of the international intellectual property rights system: patent protection for the pharmaceutical industry and access to medicines].
Chaves GC; Oliveira MA; Hasenclever L; de Melo LM
Cad Saude Publica; 2007 Feb; 23(2):257-67. PubMed ID: 17221075
[TBL] [Abstract][Full Text] [Related]
6. [Essential medicines and the TRIPS Agreement: collision between the right to health and intellectual property rights].
Allard Soto R
Salud Colect; 2015 Mar; 11(1):9-21. PubMed ID: 25853827
[TBL] [Abstract][Full Text] [Related]
7. Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016.
't Hoen EF; Veraldi J; Toebes B; Hogerzeil HV
Bull World Health Organ; 2018 Mar; 96(3):185-193. PubMed ID: 29531417
[TBL] [Abstract][Full Text] [Related]
8. Public health-oriented intellectual property and trade policies in Africa and the regional mechanism under Trade-Related Aspects of Intellectual Property Rights amendment.
Adekola TA
Public Health; 2019 Aug; 173():1-4. PubMed ID: 31203136
[TBL] [Abstract][Full Text] [Related]
9. Why are generic drugs being held up in transit? Intellectual property rights, international trade, and the right to health in Brazil and beyond.
Rosina MS; Shaver L
J Law Med Ethics; 2012; 40(2):197-205. PubMed ID: 22789040
[TBL] [Abstract][Full Text] [Related]
10. How do public health safeguards in Indian patent law affect pharmaceutical patenting in practice?
Sampat BN; Amin T
J Health Polit Policy Law; 2013 Aug; 38(4):735-55. PubMed ID: 23645877
[TBL] [Abstract][Full Text] [Related]
11. Affordable antiretroviral drugs for the under-served markets: how to expand equitable access against the backdrop of challenging scenarios?
Dionisio D; Cao Y; Hongzhou L; Kraisintu K; Messeri D
Curr HIV Res; 2006 Jan; 4(1):3-20. PubMed ID: 16454707
[TBL] [Abstract][Full Text] [Related]
12. The role of intellectual property rights on access to medicines in the WHO African region: 25 years after the TRIPS agreement.
Motari M; Nikiema JB; Kasilo OMJ; Kniazkov S; Loua A; Sougou A; Tumusiime P
BMC Public Health; 2021 Mar; 21(1):490. PubMed ID: 33706726
[TBL] [Abstract][Full Text] [Related]
13. Raising the Barriers to Access to Medicines in the Developing World - The Relentless Push for Data Exclusivity.
Diependaele L; Cockbain J; Sterckx S
Dev World Bioeth; 2017 Apr; 17(1):11-21. PubMed ID: 26818105
[TBL] [Abstract][Full Text] [Related]
14. Impact of the World Trade Organization TRIPS agreement on the pharmaceutical industry in Thailand.
Supakankunti S; Janjaroen WS; Tangphao O; Ratanawijitrasin S; Kraipornsak P; Pradithavanij P
Bull World Health Organ; 2001; 79(5):461-70. PubMed ID: 11417042
[TBL] [Abstract][Full Text] [Related]
15. Basic survival needs and access to medicines--coming to grips with TRIPS: conversion + calculation.
Van Puymbroeck RV
J Law Med Ethics; 2010; 38(3):520-49. PubMed ID: 20880239
[TBL] [Abstract][Full Text] [Related]
16. University contributions to the HPV vaccine and implications for access to vaccines in developing countries: addressing materials and know-how in university technology transfer policy.
Crager SE; Guillen E; Price M
Am J Law Med; 2009; 35(2-3):253-79. PubMed ID: 19697749
[TBL] [Abstract][Full Text] [Related]
17. Changes to intellectual property policy in South Africa: putting a stop to evergreening?
Hill JE
Expert Opin Ther Pat; 2014 Aug; 24(8):839-43. PubMed ID: 24965317
[TBL] [Abstract][Full Text] [Related]
18. The Effects of Intellectual Property Rights on Access to Medicines and Catastrophic Expenditure.
Jung Y; Kwon S
Int J Health Serv; 2015; 45(3):507-29. PubMed ID: 26077858
[TBL] [Abstract][Full Text] [Related]
19. Impact on access to medicines from TRIPS-Plus: a case study of Thai-US FTA.
Kessomboon N; Limpananont J; Kulsomboon V; Maleewong U; Eksaengsri A; Paothong P
Southeast Asian J Trop Med Public Health; 2010 May; 41(3):667-77. PubMed ID: 20578557
[TBL] [Abstract][Full Text] [Related]
20. Patents and access to drugs in developing countries: an ethical analysis.
Sterckx S
Dev World Bioeth; 2004 May; 4(1):58-75. PubMed ID: 15086374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
